WE CONDUCT RESEARCH ON THE ROLE OF MICROBES IN VARIOUS HUMAN CONDITIONS. OUR PRIMARY FOCUS IS THE MICROBIOTA WHICH INFLUENCES UROLOGICAL OUTCOMES.
Jeremy Burton holds the Chair in Human Microbiome and Probiotics based in the Lawson Health Research Institute. He is an Associate Professor in the Division of Urology, Department of Surgery and Department of Microbiology & Immunology at Western University.
B.Sc., M.Sc., Ph.D. Microbiology and Immunology, dBA, University of Otago, New Zealand
September 29, 2020
A new review in a brand new journal. Issues beyond resistance: inadequate antibiotic therapy and bacterial hypervirulence. PhD graduate, Dr. Lee Goneau's swan song paper.
September 22, 2020
Ureteral Stent Microbiota Is Associated with Patient Comorbidities but Not Antibiotic Exposure. Dr. Kait Al and Dr. Bjazevic featured by CTV.
September 10, 2020
Using a Drosophila model, we show how a beneficial strain of oxalate-degrading bacteria can reduce the risk of kidney stones
Talking about our collaborative studies using Faecal Microbiota Transplant (FMT) in combination with immune therapies. Also in Forbes.
March 20, 2020
PROBIOTICS & MICROBIOTA IN UROLOGY
A opinion piece on the future of probiotics in Urology published at the American Urological Association AUA News. The future in this area is bright if some bold steps are taken.
May 24, 2020
A randomised control study part of Dr Lauren Craven's PhD work published in the American Journal of Gastroenterology
June 10, 2020
CTV News piece: A team of researchers with Western University and the Lawson Health Research Institute were looking at whether the procedure could help treat non-alcoholic fatty liver disease (NAFLD), a type of liver disease caused by obesity.
September 24, 2020
Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients published in Nature Communications. See our blog post HERE